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ell death and survival of neural progenitor (NP) cells
are determined by signals that are largely unknown.
We have analyzed pro-apoptotic signaling in indi-
vidual NP cells that have been derived from mouse embry-
onic stem cells. NP formation was concomitant with elevated
apoptosis and increased expression of ceramide and prostate
apoptosis response 4 (PAR-4). Morpholino oligonucleotide-
mediated antisense knockdown of PAR-4 or inhibition
of ceramide biosynthesis reduced stem cell apoptosis,
whereas PAR-4 overexpression and treatment with ceramide
analogs elevated apoptosis. Apoptotic cells also stained for
C
 
proliferating cell nuclear antigen (a nuclear mitosis marker
protein), but not for nestin (a marker for NP cells). In mitotic
cells, asymmetric distribution of PAR-4 and nestin resulted
in one nestin(
 
 
 
)/PAR-4(
 
 
 
) daughter cell, in which ceramide
elevation induced apoptosis. The other cell was nestin(
 
 
 
),
but PAR-4(
 
 
 
), and was not apoptotic. Asymmetric distribution
of PAR-4 and simultaneous elevation of endogenous cer-
amide provides a possible mechanism underlying asymmetric
differentiation and apoptosis of neuronal stem cells in the
developing brain.
 
Introduction
 
Apoptosis of neuronal stem cells is required to avoid hyper-
proliferation of brain tissue during embryonal mouse brain
development (Blaschke et al., 1996; Sommer and Rao
2002). Consistent with this, caspase 9 and Apaf1 knockout
mice show extreme forebrain malformation at gestational d
E14 due to overproliferation of neural stem cells (Cecconi et
al., 1998; Kuida et al., 1998). Recently, we have shown that
during d E12–E16 of mouse development, brain ceramide
and prostate apoptosis response 4 (PAR-4), an endogenous
inhibitor of atypical PKC
 
 
 
, are elevated (Bieberich et al.,
2001). This is concurrent with the presence of numerous
apoptotic cells in the subventricular/ventricular zone. Also,
we have shown that both ceramide and PAR-4 are required
to induce apoptosis in neuronal cells via down-regulation of
PKC
 
 
 
 and MAPK-dependent cell survival pathways. Our
analyses provide evidence that ceramide/PAR-4–induced
apoptosis is a major mechanism of active cell death in devel-
oping mouse brain. This hypothesis is consistent with the
observation that ceramide triggers cytochrome 
 
c
 
 release from
mitochondria and subsequent activation of the caspase 9–
and caspase 3–dependent signaling pathway for apoptosis
(Hakem et al., 1998; Movsesyan et al., 2002). However, we
have also found that at d E14, several pro- or anti-apoptotic
stimuli are simultaneously up-regulated, indicating a complex
and interdependent regulation of cell division, apoptosis,
and cell survival in neural stem cells (Bieberich et al., 2001).
According to a current model, apoptosis of neuronal stem
cells may occur very soon after cell division, leaving one
daughter cell committed to cell death, whereas the other one
may further proliferate or differentiate (Kuan et al., 2000;
Sommer and Rao, 2002). This asymmetric model of apoptosis
during neural differentiation implies that cell death or survival
is regulated immediately on cell division of stem cells. Most
 
Address correspondence to Erhard Bieberich, Institute of Molecular
Medicine and Genetics, Medical College of Georgia, 1120 15th Street,
Room CB-2803, Augusta, GA 30912. Tel.: (706) 721-9113. Fax: (706)
721-8685. email: ebieberich@mail.mcg.edu
Key words: embryonic stem cells; neuronal differentiation; neuroprogenitor;
sphingolipid; nestin
 
Abbreviations used in this paper: Bcl-2, b-cell lymphoma 2; EB, embryoid
body; ES, embryonic stem; FB1, fumonisin B1; FGF-2, fibroblast
growth factor 2; HPTLC, high performance thin layer chromatography;
NP, neural progenitor; PAR-4, prostate apoptosis response 4; PCNA,
proliferating cell nuclear antigen; SPT, serine palmitoyltransferase.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 
470 The Journal of Cell Biology 
 
|
 
 
 
Volume 162, Number 3, 2003
 
recently, asymmetric distribution of the Notch inhibitor
Numb to one daughter cell during mitosis of neural precur-
sor cells has been suggested to regulate cell death in 
 
Drosoph-
ila
 
 and mammals (Orgogozo et al., 2002; Shen et al., 2002).
We hypothesized that asymmetric cell death of mammalian
neural progenitors (NPs) may also result from the unequal
distribution of pro- or anti-apoptotic factors to the daughter
cells during cell division. We tested this hypothesis by ana-
lyzing the expression of several pro- or anti-apoptotic pro-
teins involved in ceramide-induced apoptosis of differentiat-
ing embryonic stem (ES) cells and their correlation with cell
division and death.
The observation that ceramide and PAR-4 are concur-
rently elevated during the peak time of apoptosis in embry-
onic mouse brain (Bieberich et al., 2001) prompted us to
determine the function of ceramide and PAR-4 in the
regulation of NP cell death. Mouse ES cells have been
shown to differentiate in culture into neurons and glial cells
by recapitulating the stages of neuronal differentiation that
occur in vivo (Fraichard et al., 1995; Mayer-Proschel et al.,
1997). In particular, the formation of NP cells is a critical
stage of commitment and differentiation into neuronal and
glial cells. In ES cells, this stage occurs during serum depri-
vation on embryoid body (EB) formation, and during the
expansion of EB-derived cells in serum-free medium plus fi-
broblast growth factor 2 (FGF-2; Hancock et al., 2000). In
embryonic mouse brain, these stages probably correspond to
populations of differentiating neural stem cells in the sub-
ventricular/ventricular zone between E12 and E18 (Hatten
1999). Accordingly, in vitro neural differentiation of ES
cells by serum deprivation is a valid model for the functional
correlation of ceramide and PAR-4 elevation with induction
of apoptosis in both, in vitro differentiating ES cells and
neural stem cells in embryonic mouse brain.
To define the molecular mechanisms underlying cer-
amide-induced apoptosis in NP cells, we have analyzed the
expression levels and patterns of ceramide and PAR-4 in NP
cells derived from ES cells. We have used high performance
TLC (HPTLC) of lipid extracts of differentiating ES cells to
measure ceramide levels during differentiation. The intracel-
lular distribution of ceramide was detected using an anti-
body that has been used for specific immunostaining of
ceramide in fixed cells (Grassme et al., 2001). Immunofluo-
rescence microscopy of NP cells revealed that PAR-4, cer-
amide, and the intermediate filament protein nestin are
asymmetrically distributed during cell division. The coex-
pression of PAR-4 and ceramide was concurrent with
TUNEL staining for apoptosis. The other daughter cell that
did not express PAR-4 was nestin positive and was not apop-
totic. Thus, asymmetric distribution of PAR-4 may regulate
ceramide-induced apoptosis during the proliferation and
differentiation of stem cells.
 
Results
 
Ceramide expression is up-regulated during neural 
differentiation of ES cells
 
Mouse ES cells were differentiated after a serum deprivation
protocol outlined in Fig. 1 A. This method yielded ES-
derived cell cultures highly enriched in neural cells after 25 d
in culture (Okabe et al., 1996; Hancock et al., 2000). Neu-
ronal differentiation was verified by staining of marker pro-
teins using immunoblotting (Fig. 1 B) and immunofluo-
rescence microscopy (Fig. 2). ES cell differentiation was
initiated by aggregating the ES cells (Fig. 2 A) to form EBs.
The EBs were incubated in suspension culture in serum-
containing medium for 4 d (Fig. 1 A, stages EB1–EB4). The
differentiating EBs were then plated on tissue culture plates
and allowed to attach in serum-containing medium for 1 d,
and were then shifted to serum-free medium for three addi-
tional days of culture (Fig. 1 A and Fig. 2 A, EB5–EB8).
The Oct4 protein, a marker of pluripotent stem cells (Pesce
and Scholer, 2001), was detected in the EB8 stage, reflecting
the presence of residual undifferentiated pluripotent stem
cells within the EBs (Fig. 1 B, lane 1). No Oct4 expression
was detectable after the dissociation and replating of the EBs
in serum-free, FGF-2–containing medium (Fig. 1, A and B;
lanes 2–4). The serum-free conditions did not support the
proliferation of nonneural cell types, whereas FGF-2 sup-
ported the robust proliferation of NP cells (Fig. 1 A, stages
NP1–NP4; Fig. 2 B shows NP2). The early neural precursor
cell marker vimentin was only detected in EB8 and NP2
Figure 1. In vitro neuronal differentiation of ES cells, overview, 
and marker protein expression. ES, embryonic stem cell; EB, 
embryoid body; NP, neuronal progenitor cell; GRP, glial restricted 
precursor cells; NRP, neuronal restricted precursor cell (for 
terminology, see Mayer-Proschel et al., 1997; Wu et al., 2002). In 
B, immunostaining for marker proteins was performed with protein 
extracts from stem cells at the differentiation stages shown in A.T
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(Fig. 1 B, lane 1 and lane 2), whereas the NP marker nestin
was detected at low levels at EB8 and at high levels at NP2
and D1 (Fig. 1 B, lanes 1–3; Fig. 2 B). The expansion of
EBs was followed by a massive increase of the number of
nestin-positive progenitor cells from 
 
 
 
60% (Fig. 2 B, NP2)
to 
 
 
 
80% at NP4. Differentiation of NP cells to glial cells
and neurons was initiated by withdrawal of FGF-2 from the
culture medium (Fig. 1 A; stages D1–D4) and verified by
staining for the glial fibrillary acidic protein (GFAP) and the
neuronal marker proteins microtubuli-associated protein 2
(MAP-2) and synaptophysin (Figs. 1 B, lane 3 and lane 4;
Fig. 2 C). No expression of NP markers was detected after
D1 (Fig. 1 B, lane 4). Expression of GFAP was detected at
D1 and D4, whereas MAP-2 and synaptophysin were only
detected at D4, the most mature differentiation stage tested.
It should be noted that 
 
 
 
20% of Hoechst-stained cells
showed neither GFAP nor MAP-2 staining, which verifies
that the portion of nonneuronal cells within the fully differ-
entiated culture was negligibly low (Fig. 2 C).
To measure ceramide levels during ES cell differentiation,
50–100 mg of cells were harvested at different time points
during differentiation. Sphingolipids were isolated using or-
ganic solvent extraction. As shown in Fig. 3 (A and B),
quantitative HPTLC and DAG kinase assay revealed that fi-
broblast-free, undifferentiated ES cells (Fig. 3 A, lane 2)
contained 
 
 
 
0.2 
 
 
 
 0.1 
 
 
 
g ceramide/mg cell protein. After
4 d of EB formation (EB4 stage), ceramide had increased to
0.4 
 
 
 
 0.1 
 
 
 
g ceramide/mg cell protein (Fig. 3 A, lane 3).
Endogenous ceramide was further elevated to 1.0 
 
 
 
 0.2 
 
 
 
g/
mg cell protein by the EB8 stage of differentiation (Fig. 3 A,
Figure 2. In vitro neuronal differentiation of ES cells, morphology, 
and histochemical characterization. (A) ES6, ES cells 2 d in feeder-
free cultures; EB8, EBs after 4 d in serum-free medium; (B) NP2, NPs 
after 2 d in FGF-2 containing, serum-free medium; nestin (red), 
Hoechst (blue); (C) D4, differentiated neurons and glial cells after 
4 d in serum-containing medium; MAP-2 (green), GFAP (red), 
Hoechst (blue). For differentiation stages, see Fig. 1A. GFAP, glial 
fibrillary acidic protein; MAP-2, microtubuli-associated protein 2.
Figure 3. Ceramide content and apoptosis during in vitro neuronal 
differentiation of ES cells. (A) Neutral lipids were purified from 
differentiating ES cells and a lipid amount corresponding to 750  g 
of cellular protein/lane separated by HPTLC in the running solvent 
CH3Cl/HOAc (9:1, vol/vol). Lipids were stained with the cupric acetate 
reagent. Ceramide (open bars) was quantified by densitometric 
analysis and comparison with known amounts of standard lipid 
(N-oleoyl sphingosine). Lane 1, ceramide standard from bovine 
brain; lane 2, fibroblast-freed ES cells, after 4 d in culture; lane 3, 
EBs at the EB4 stage; lane 4, EBs at the EB8 stage; lane 5, NPs at the 
NP2 stage; lanes 6–8, three terminal differentiation stages, 24 (D1 
stage), 48 (D2 stage), and 96 h (D4 stage) on cultivation of NP cells 
in serum-containing medium; lanes 9–11, N-oleoyl sphingosine, 
250, 500, and 1,000 ng, respectively. (B) Lipids were extracted from 
differentiated ES cells and the amount of ceramide quantified using 
the DAG kinase assay. Apoptosis (solid bars) was determined by 
TUNEL staining. For HPTLC, DAG kinase, and TUNEL analyses, 
experiments were performed with five independent ES cultures. 
The bars show the standard mean and deviation of percentage of 
TUNEL-positive cells that were counted in five areas of 200 cells in 
each experiment.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 
472 The Journal of Cell Biology 
 
|
 
 
 
Volume 162, Number 3, 2003
 
lane 4). The increased ceramide concentration was main-
tained through the NP2 stage of differentiation (Fig. 3 A,
lane 5). In the D1 stage of differentiation, the ceramide con-
centration was found to be reduced by 70% (0.3 
 
 
 
 0.1 
 
 
 
g
ceramide/mg cell protein) and did not change significantly
after 4 d of differentiation (Fig. 3 A; D1, D2, and D4, lanes
6, 7, and 8, respectively). Together, these results indicate
that the peak elevation of ceramide occurs during the initial
formation of NP cells on serum deprivation of EBs and dur-
ing NP expansion in the presence of FGF-2.
 
Apoptosis during neuroprogenitor expansion is 
dependent on ceramide elevation
 
We determined the degree of apoptosis in differentiating ES
cultures because we have previously proposed that ceramide
elevation induces apoptosis in NP cells (Bieberich et al.,
2001). As shown in Fig. 3 B, the degree of apoptosis was
quantified by counting TUNEL-stained cells. Apoptosis was
elevated at the EB8 stage (20 
 
 
 
 5%) and was highest at the
NP2 stage (35 
 
 
 
 5%). The fraction of apoptotic cells rap-
idly decreased on induction of neural differentiation, and
was already 
 
 
 
20% at D1. Differentiated neurons at D4 did
not show a significant degree of apoptosis (
 
 
 
10 
 
  
 
5%).
These results show that the peak time of apoptosis coincided
with the peak elevation of endogenous ceramide. Consistent
with this, inhibition of ceramide biosynthesis by incuba-
tion with 25 
 
 
 
M of the ceramide synthase inhibitor fumoni-
sin B1 (FB1) or 50 nM of the serine palmitoyltransferase (SPT)
inhibitor myriocin for 48 h reduced the degree of apoptosis
at the EB8 and NP2 stage by 
 
 
 
50%. Fig. 4 (right) shows
that at the NP2 stage, apoptosis proceeded in differentiating
ES cells that did not stain for nestin (Fig. 4 A). In these cells,
FB1 significantly reduced the degree of apoptosis (Fig. 4 B).
Apoptosis was restored by the addition of 30 
 
 
 
M N-acetyl
sphingosine (C2-ceramide; not depicted), 80 
 
 
 
M of the
novel ceramide analogue N-oleoyl serinol (Fig. 4 C, S18; for
review see Bieberich et al., 2001), or 1 
 
 
 
M of natural cer-
amide (not depicted) that was extracted from differentiating
ES cells. Together, these results showed that elevation of en-
dogenous ceramide was a prerequisite for the induction of
apoptosis in differentiating ES cells at the NP2 stage.
 
Ceramide-induced apoptosis is dependent on PAR-4 
expression in nestin-negative cells
 
Previously, we have reported that expression of PAR-4, an
inhibitor protein of PKC
 
 
 
, is the prerequisite for induction
of apoptosis by incubation of differentiating ES cells with
S18 or C2-ceramide (Bieberich et al., 2001). These results
were confirmed by incubation of FB1-treated cells at the
NP2 stage with S18, C2-ceramide, or natural ceramide that
was extracted from differentiating ES cells. Fig. 4 (left) shows
that apoptosis was only seen in cells that expressed PAR-4
(Fig. 4 A). S18 or ceramide incubation did not alter the
number of PAR-4–positive cells, but it restored the degree of
apoptosis to that found with cells that were not pretreated
with FB1. S18 incubation did not alter the concentration of
endogenous ceramide, indicating that ceramide elevation was
not a by-product of apoptotic cells, but the cause of apopto-
Figure 4. Alteration of neural stem cell 
apoptosis by inhibition of ceramide 
biosynthesis or incubation with ceramide 
analogs. (A–C) Differentiating ES cells at 
the NP2 stage were immunostained for 
PAR-4 (red, left) and nestin (red, right), 
apoptotic cells were TUNEL stained 
(green), and nuclei were counterstained 
with Hoechst dye (blue). A, control 
cells without FB1 or the novel ceramide 
analogue S18; B, cells incubated for 48 h 
with 25  M FB1; C, cells incubated for 
48 h with FB1 (ceramide depletion) 
followed by overnight treatment with 
80  M S18. Arrows indicate apoptotic 
cells.T
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sis. Notably, the majority of apoptotic cells (
 
 
 
90%) that
stained for PAR-4 were nestin negative (Fig. 4).
To suppress PAR-4 expression, ES cells at the NP1 stage
were transfected with a PAR-4–specific morpholino phos-
phorodiamidate antisense oligonucleotide (morpholino) that
was designed on the basis of a previously published antisense
oligonucleotide sequence (Guo et al., 1998, 2001). Mor-
pholinos have been shown to avoid many of the pitfalls asso-
ciated with conventional antisense oligonucleotides, and have
 
been successfully used for transfection of embryos and cul-
tured cells (Morcos, 2001). Fig. 5 A (left) shows NP cells
48 h after transfection with a standard morpholino provided
as negative control. The number of TUNEL-stained cells in the
negative control was equivalent to that found with untrans-
fected cells (35%, see Fig. 3 B), indicating that the degree of
apoptosis was not affected due to any unspecific effect of the
morpholino. This result was consistent with the observation
that the expression level of PAR-4 in untransfected and con-
trol morpholino-transfected NP cells was the same (Fig. 5 B,
lane 1 and lane 2). Incubation of control morpholino-trans-
fected NP cells with 80 
 
 
 
M S18 increased the number of ap-
optotic cells to that found with S18-treated, untransfected
cells (
 
 
 
80%). However, transfection of NP cells with a PAR-
4–specific antisense morpholino reduced S18-induced apop-
tosis to a level 
 
 
 
30% (Fig. 5 A, right). Consistently, trans-
fection with the PAR-4 antisense morpholino suppressed the
expression level of PAR-4 to 
 
 
 
25% of that detected in un-
transfected cells (Fig. 5 B, lane 3).
To determine the effect of elevated PAR-4 expression, we
transfected myriocin-treated ES cells at the NP1 stage with
PAR-4 linked to far-red–shifted red fluorescent protein (Fig.
5 B, lane 4; PAR-4-RFP). Fig. 5 C shows that PAR-4-RFP
expression by itself did not induce apoptosis in the trans-
fected cells. However, apoptosis was observed when trans-
fected cells were incubated with 40 
 
 
 
M S18, a concentration
at which no or only a low degree of ceramide analogue-induced
apoptosis occurred in untransfected or mock (RFP)-trans-
fected cells (unpublished data). Apoptosis was induced al-
most exclusively in PAR-4-RFP–expressing cells, whereas
the population of cells without PAR-4-RFP remained unaf-
fected. In summary, these results show that the expression
and/or elevation of PAR-4 were the prerequisite for cer-
amide-induced apoptosis in differentiating ES cells.
 
Apoptosis is induced by simultaneous up-regulation of 
PAR-4 and ceramide biosynthesis
 
To identify the genes involved in the regulation of apoptosis
in differentiating ES cells, we have determined the temporal
expression pattern of pro- or anti-apoptotic proteins and
ceramide biosynthesis/metabolism during EB and NP for-
mation. Fig. 6 A shows that PAR-4 expression was signifi-
cantly elevated at the EB8 and NP2 stages (Fig. 6 A, lane 1
and lane 2). By the first day of neural differentiation (D1),
the PAR-4 level dropped to 
 
 
 
20% of that at NP2 (Fig. 6 A,
lane 2 and lane 3). The peak time of PAR-4 expression at the
NP2 stage was concurrent with caspase 3 activation and in-
creased proliferating cell nuclear antigen (PCNA) levels (Fig.
6 A, lane 2). PCNA is a marker for mitotic cells (Chan et al.,
2002), indicating that PAR-4 elevation and caspase 3 activa-
tion is predominant at stages with a large number of prolif-
erating stem cells. The expression of PKC
 
 
 
 did not change
during neuronal differentiation. PKC
 
 
 
 activity is inhibited
by ceramide-enhanced binding of PAR-4, leading to an up-
regulation of the caspase 9– and caspase 3–dependent ap-
optotic pathway (Diaz-Meco et al., 1996; Mattson, 2000).
We confirmed the participation of caspase 9 in ceramide-
induced apoptosis of differentiating ES cells by the observa-
tion that preincubation with the cell-permeable caspase 9 in-
hibitor peptide LEHD-CHO suppressed apoptosis that was
Figure 5. Alteration of neural stem cell apoptosis by antisense 
knockdown or overexpression of PAR-4. (A) Differentiating 
ES cells at the NP1 stage were transfected with a morpholino 
phosphorodiamidate antisense oligonucleotide against PAR-4, 
and 48 h later (NP3 stage), were incubated overnight with 80  M 
S18. The figure shows PAR-4 (red), nestin (green), and TUNEL 
(blue) staining of cells transfected with standard control antisense 
oligonucleotide (left), and cells transfected with PAR-4–specific 
antisense oligonucleotide followed by incubation with S18 (right). 
(B) Staining of PAR-4 on immunoblots of protein from differentiating 
ES cells (NP3 stage) that were transfected with or without PAR-4–
specific antisense oligonucleotide or PAR-4-RFP, respectively. Lane 
1, untransfected (UT) NP cells; lane 2, NP cells transfected with 
standard control antisense oligonucleotide (Con); lane 3, NP cells 
transfected with PAR-4–specific antisense oligonucleotide (Anti); 
lane 4, NP cells transfected with PAR-4-RFP. (C) In differentiating 
ES cells at the EB8 stage, inhibition of ceramide biosynthesis was 
initiated by incubation with 50 nM myriocin, and was then maintained 
throughout the subsequent differentiation stages. After NP expansion 
(NP1 stage), cells were transfected with PAR-4-RFP, and 48 h later 
(NP3 stage), were incubated overnight with 80  M S18 (right). The 
figure shows phase contrast and overlay with RFP (red) fluorescence. 
Arrow in A indicates apoptotic cells.T
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inducible with S18 or natural ceramide isolated from ES
cells. Upstream regulators of caspase 3, in particular, anti-
apoptotic b-cell lymphoma 2 (Bcl-2) and pro-apoptotic Bcl-2
antagonist of death (Bad) were inversely regulated, suggest-
ing activation of caspase 3 via the mitochondrial death path-
way (Fig. 6 A). However, a high degree of Bad phosphoryla-
tion was detectable at NP2 (Fig. 6 A, lane 2) indicating the
presence of both apoptotic and anti-apoptotic signaling at
this stage. The expression of Bad dropped and that of Bcl-2
increased during D1 and D4, consistent with lower levels of
caspase 3 activation and apoptosis at these differentiation
stages (Fig. 6 A, lane 3 and lane 4).
We also analyzed the gene expression of PAR-4, PKC
 
 
 
,
and SPT that catalyzes the initial reaction of ceramide
biosynthesis using RT-PCR. The highest level of PAR-4
mRNA was found at the EB8 stage (Fig. 6 B, lane 2). Inter-
estingly, the level of PAR-4 mRNA drops within 48 h from
EB8 to NP2 (Fig. 6 B, lane 2 and lane 3), although the NP2
stage shows the highest concentration of PAR-4 protein
(Fig. 6 A, lane 2). The transcription of PKC
 
 
 
 appears not to
be modulated during neuronal differentiation, which is con-
sistent with the unchanged level of protein expression. There
is a more than 10-fold increase in gene expression of SPT
subunit 1 (SPT1) at the EB8 stage, whereas the transcription
of the SPT subunit 2 (SPT2) mRNA remains unchanged at
all differentiation stages from EB8 to D4 (Fig. 6 B, lanes
2–4). Up-regulation of SPT1 gene expression is consistent
with elevated ceramide biosynthesis at EB8 and NP2 be-
cause SPT1 activates SPT2 (Hanada et al., 1998). Together,
our results show that apoptosis of differentiating ES cells at
the NP2 stage is most likely induced by up-regulation of cer-
amide biosynthesis and elevation of PAR-4 expression.
 
Asymmetric distribution of PAR-4 and nestin during 
mitosis of neuronal stem cells
 
The apparent paradoxical elevation of both the proliferation
marker PCNA and the pro-apoptotic, active caspase 3 at the
EB8 and NP2 stages of ES cell differentiation prompted us
to examine the patterns of mitosis and apoptosis in individ-
ual cells by immunofluorescence microscopy for mitosis/
apoptosis markers and BrdU labeling. We also analyzed
whether mitosis or apoptosis is predominant in NP cells by
immunofluorescence staining for nestin. As shown in Table
I and Fig. 7 A, simultaneous staining by TUNEL assay
(green) and antibodies against nestin (red) and PCNA (far-
red, pseudo-colored in pink) revealed that the major portion
(92%) of TUNEL-positive cells were nestin negative (see
also Fig. 4). Most of the TUNEL-positive cells (75%) ex-
pressed PCNA as well (overlay yields white-colored cells in
Fig. 7 A), indicating that apoptosis followed immediately af-
ter mitosis or during the attempt to enter the next mitotic
cycle. However, no TUNEL signal was detected if cells coex-
pressed PCNA and nestin. These observations prompted us
to look specifically for the distribution of pro-apoptotic sig-
nals in proliferating cells, in particular for the expression of
PAR-4 and ceramide. In double-staining experiments for
TUNEL and one additional marker, ceramide or PAR-4 is
expressed in TUNEL-positive as well as TUNEL-negative
cells (Table I). The majority of the TUNEL-positive cells ex-
pressed PAR-4 (94%), ceramide (98%), or PCNA (75%),
whereas TUNEL-negative cells showed a lower frequency
for PAR-4 (27%), ceramide (34%), or PCNA (45%) expres-
sion (Table I). In double-staining experiments for two mark-
ers, PAR-4 and ceramide are independently distributed
(31% observed vs. 24% expected frequency for the expres-
sion of both ceramide and PAR-4) within the total cell pop-
ulation. However, in triple-staining experiments, 97% of the
TUNEL-positive cells show PAR-4 and ceramide expres-
Figure 6. Expression of differentiation markers 
and pro- or anti-apoptotic proteins in differentiating 
ES cells. (A) During in vitro neural differentiation 
of ES-J1 mouse ES cells, protein was extracted 
from the cells, separated by SDS-PAGE, and 
blotted onto nitrocellulose. Each lane shows the 
immunostaining corresponding to 35  g cell protein. 
See Fig. 1 for definition of differentiation stages. 
The protein analysis was performed with five 
independent differentiation experiments. (B) RNA 
was isolated from differentiating ES-J1 cells (see Fig. 1 
for definition of differentiation stages) and subjected 
to RT-PCR. SPT1/2, SPT subunit 1 and 2. Each 
experiment was repeated four times.
 
Table I. 
 
Correlation of apoptosis and ceramide or marker protein 
expression during neuroprogenitor formation (NP2 stage)
TUNEL
 
 
 
63 
 
 
 
 4
TUNEL
 
 
 
TUNEL
 
 
 
137 
 
 
 
 11
TUNEL
 
 
 
Total
200
Total
 
%% %
 
PAR-4 59 
 
 
 
 6 94 31 
 
 
 
 3 27 90 
 
 
 
 94 5
Nestin 5 
 
 
 
 2 8 107 
 
 
 
 6 78 112 
 
 
 
 10 56
PCNA 47 
 
 
 
 5 75 61 
 
 
 
 5 45 108 
 
 
 
 95 4
Ceramide 61 
 
 
 
 6 98 46 
 
 
 
 4 34 107 
 
 
 
 9  54
Differentiating ES cells were grown on coverslips and fixed at the NP2
stage. TUNEL staining (green fluorescence) was followed by indirect
immunofluorescence staining using secondary antibodies that were linked
to Cy3/Alexa
 
®
 
 546 (red fluorescence) or Cy5 (far-red). For species of
primary antibodies, see Materials and methods. Hoechst staining was used
for the identification of individual cells. The number of cells (total cell count
of 200 in five independent areas) that were TUNEL positive (average of
63 
 
 
 
 4) or negative (average of 137 
 
 
 
 11) and stained for another marker,
as indicated, is shown.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 
Regulation of neural progenitor cell death |
 
 Bieberich et al. 475
 
sion, whereas less than 2% of the TUNEL-negative cells are
stained for PAR-4 as well as ceramide. Together, these re-
sults indicate that the expression of both PAR-4 and cer-
amide is required to induce apoptosis in proliferating
(PCNA positive) stem cells or NP cells. This assumption
was also supported by immunostaining for BrdU incorpora-
tion in apoptotic cells. Fig. 7 B shows that in differentiating
ES cells at the NP2 stage, apoptosis is observed in 70% of
cells within 5 h after BrdU labeling. Hence, in differentiat-
ing ES cells at the NP stage, apoptosis (activation of caspase
3) rapidly follows mitosis (BrdU incorporation).
The results from ceramide and PAR-4 double-immuno-
staining experiments suggested that either ceramide or
PAR-4 was sequestered to only one daughter cell during cell
division. We identified mitotic cells in anaphase (mitosis
stage VII) and telophase (mitosis stage VIII) by the polar-
ized orientation of nuclei on fixation and staining with
Hoechst dye, a useful marker for the identification of differ-
ent mitotic stages (Leblond and El-Alfy, 1998). 10 out of
5,000 cells were found to be in mitosis stage VII or VIII.
Ceramide (Fig. 8, green) was homogenously distributed to
the two daughter cells, whereas PAR-4 (Fig. 8, red) was se-
questered to only one daughter cell (Fig. 8 B). The daugh-
ter cells with elevated PAR-4 appeared apoptotic, as PAR-4
colocalized with ceramide in membrane blebs that are typi-
cal for apoptosis (Fig. 8, D–D
 
  
 
). Ceramide-induced apop-
tosis in PAR-4–positive cells was executed by the caspase
9-to-caspase 3 cascade as shown by coimmunostaining of
elevated PAR-4 and cleaved caspase 3 in TUNEL–positive
cells (Fig. 8, E and E
 
 
 
).
The lack of nestin expression in PAR-4–positive cells sug-
gested that nestin and PAR-4 were sequestered asymmetri-
cally to the daughters of dividing NP cells. Fig. 9 shows that
immunostaining for nestin (green) and PAR-4 (red) was in-
deed asymmetrically distributed in mitosis stage VIII cells
(Fig. 9 A). The PAR-4–positive (but nestin-negative) cells
underwent apoptosis (top right), whereas the nestin-posi-
tive cells were nonapoptotic and expressed either none or
significantly less PAR-4 than nestin-negative cells. The ab-
sence of nestin staining in apoptotic cells (Fig. 9 B, arrows)
Figure 7. Apoptosis of differentiating 
ES-J1 ES cells at the NP2 stage of 
differentiation. Multiple, indirect 
immunofluorescence staining of 
differentiating ES-J1 cells 48 h on replating 
of EB8 cells (NP2 stage). (A) Nestin, (Cy3, 
red); PCNA, (Cy5, far-red, pseudo-colored 
as pink); TUNEL, FITC (green); Hoechst 
(blue). White color shows PCNA- and 
TUNEL-stained (apoptotic) cells. Pink 
staining shows cells that are PCNA-
positive, but not apoptotic. (B) Cells at 
the NP2 stage were pulse labeled for 
3 h with BrdU, followed by fixation 
and immunostaining for BrdU (green), 
activated caspase 3 (Cy5, pseudo-colored 
as pink), and Hoechst (blue) 5 h after 
labeling. White staining shows TUNEL- 
and active caspase 3–stained cells. Pink 
staining shows only activated caspase
3–positive cells.
Figure 8. Distribution of ceramide and PAR-4 during cell division 
of ES-J1 ES cells at the NP2 stage of differentiation and caspase 3 
activation. Multiple, indirect immunofluorescence staining of 
differentiating ES-J1 cells 48 h after replating of EB8 cells (NP2 
stage). Ceramide, FITC (green); PAR-4, (Alexa
® 546, red); Hoechst 
(blue). A, mitotic cell in anaphase; B, mitotic cell in telophase; 
C, nonapoptotic cell; D–D  , apoptotic cell. Leftmost picture (D) 
shows overlay of ceramide (D ), PAR-4 (D  ), and Hoechst staining; 
E, overlays of TUNEL (green) and PAR-4 (red) staining or E , TUNEL 
(green) and activated caspase 3 (Cy5, pseudo-colored as pink) staining.T
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is consistent with the results shown in Table II and Fig. 4,
Fig. 5, and Fig. 7. These data are also consistent with the
low number of cells (6%) that costained for PAR-4 and nes-
tin (Table II). In cases where residual PAR-4 was present in
nestin-positive daughter cells, the PAR-4 and nestin were
clearly separated (Fig. 9 B). Together, these observations
suggest that PAR-4 is partitioned specifically into nestin-
negative daughter cells.
 
Discussion
Our results show that NP cells containing high levels of
both ceramide and PAR-4 undergo apoptosis at high fre-
quency. Several lines of evidence show that this elevation is
the cause rather than the effect of apoptosis. Inhibition of
ceramide biosynthesis with FB1 or myriocin reduces the de-
gree of apoptosis, which can be restored by the addition of
natural ceramide or ceramide analogs. Restoration of apop-
tosis is not accompanied by elevation of endogenous cer-
amide, ruling out a significant degree of ceramide formation
by hydrolysis of ceramide derivatives in dying cells. How-
ever, elevation of endogenous ceramide, as well as the addi-
tion of natural ceramide or ceramide analogs, restores apop-
tosis only in cells with high expression of PAR-4. This
is clearly shown with NP cells that were transfected with
an anti-PAR-4-morpholino oligonucleotide or PAR-4-RFP
cDNA before incubation with ceramide analogs. Antisense
knock-down of PAR-4 eliminates S18-inducible apoptosis
even at high concentration of the ceramide analogue,
whereas overexpression results in apoptosis at low concen-
tration of S18, but only in PAR-4-RFP–expressing cells.
Thus, these experiments support the main hypothesis that
both elevation of PAR-4 and ceramide are necessary to in-
duce apoptosis.
In cultures of NP cells derived from ES cells, we found
that the expression of PAR-4 and nestin is largely segregated
to two separate populations of progenitors. Nestin( )/PAR-
4( ) cells are far less prone to apoptosis induced by high
levels of intracellular ceramide, whereas cells undergoing
apoptosis are almost always nestin( )/PAR-4( ). The ex-
pression of high levels of PAR-4 in an apoptotic subpopula-
tion is consistent with previous reports demonstrating that
overexpression of PAR-4 reduces WT1- or nuclear factor
kappa B (NF B)–mediated Bcl-2 expression, thus suppress-
ing the cells’ self-defense mechanism against ceramide-
induced apoptosis (Camandola and Mattson, 2000; Cheema
et al., 2003). The critical role of NF B for cell survival has
been shown by the observation that central neuron survival
relies on the constitutive activity of NF B (Bhakar et al.,
2002). It has also been shown that elevation of PAR-4 un-
derlies neuronal cell death in several neurodegenerative dis-
eases (Guo et al., 1998; Xie et al., 2001). To our surprise, in
cells that express both PAR-4 and nestin, the two proteins
are strictly sequestered to different parts of the cell. This se-
questration occurs already during mitotic cell division of the
parental cells, resulting in one daughter cell that is predomi-
nantly nestin-positive, while the other one contains mainly
PAR-4, but no (or only low) amounts of nestin. This reveals
a novel localization of a pro-apoptotic signal to one of the
daughter cells resulting from stem or NP cell division. The
Figure 9. Distribution of PAR-4 and nestin 
during cell division of ES-J1 ES cells at NP2 
stage of differentiation. Multiple, indirect 
immunofluorescence staining of differentiating 
ES-J1 cells 48 h on replating of EB8 cells (NP2 
stage). PAR-4, (Alexa
® 546, red); nestin, (Alexa
® 
488, green); Hoechst (blue). (A) Mitotic cell in 
anaphase/telophase, overlay of PAR-4, nestin, 
and Hoechst staining. Note the strict asymmetric 
distribution of PAR-4 and nestin. (B) Cluster of 
neuroprogenitor cells, overlay of PAR-4, nestin, 
and Hoechst staining. Arrowheads indicate 
two apoptotic PAR-4–positive cells that did not 
show any expression of nestin.
Table II. Distribution of marker proteins or ceramide during 
neuroprogenitor formation (NP2 stage)
Marker Counts Percentage of 
total counts 
(n   200)
Percent expected if 
independently 
distributed
AB A     B f(A   B)   f(A)   f(B)
PAR-4   Nestin 12   4 6% 25%
PAR-4   Ceramide 62   7 31% 24%
PAR-4   Nestin 50   7 25% 30%
Differentiating ES cells were grown on coverslips and treated as described
in the legend for Table I. Table II shows double-staining experiments for two
markers as indicated (A   B represents cells that are double-stained for A
and B). The percentage of cells in the last column has been calculated from
the frequency of each marker (A or B) in the total population of cells as
described in the “Statistical Analysis” section of Materials and methods.
Standard means and variation for five areas with 200 cells from three
independent experiments is shown.T
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asymmetric distribution of PAR-4 in the nestin-negative
daughter cells may be a mechanism to regulate the number
of differentiating cells produced from mitotically active pro-
genitor/stem cells. At present, it cannot be decided whether
the asymmetric distribution results from asymmetric inherit-
ance of nestin and PAR-4 that have already expressed before
cell division, or whether it arises from a distinct gene expres-
sion in each daughter cell during cell division.
Based on these observations, we suggest a model for asym-
metric cell division, apoptosis, and differentiation of neu-
ronal stem cells, shown in Fig. 10. Differentiating stem cells
up-regulate the expression of nestin, ceramide, and PAR-4
before or during cell division. Ceramide and PAR-4 eleva-
tion at these stages is most likely caused by up-regulation of
gene expression for PAR-4 and SPT subunit 1 (SPT1) in
EB8. This indicates regulation of de novo ceramide biosyn-
thesis and PKC  activity by the respective regulatory pro-
teins, but not by basal enzyme activities. During mitosis,
ceramide is evenly sequestered to the two daughter cells,
whereas PAR-4 and nestin are asymmetrically distributed.
The nestin( )/PAR-4( ) daughter cell undergoes cer-
amide-induced apoptosis, whereas the nestin( )/PAR-4( )
daughter cell may again divide or further differentiate into a
neuronal or glial precursor cell. At this point, rapid passage
of the mitotic cycle is desirable in order to sequester PAR-4
to one daughter cell and to avoid abortive mitosis before ac-
complishment of cell division (Liu and Greene, 2001).
There is growing evidence that elevation of ceramide is a
major regulatory factor for induction of apoptosis during in
vitro differentiation of neuronal cells (Herget et al., 2000;
Bieberich et al., 2001; Toman et al., 2002). During ongoing
differentiation, ceramide may be converted into glycosphin-
golipids and/or sphingomyelin, thereby protecting the
neuroprogenitor cells from further ceramide accumulation.
Most recently, we have found that the biosynthesis of com-
plex gangliosides from simple glycosphingolipids activates
the IGF-1-to-MAPK cell survival pathway (Bieberich et al.,
2001). Further, we have suggested that this biosynthesis is
concurrent with migration of NP cells from the ventricular
to the intermediate zone of embryonic mouse brain. Thus, it
is very likely that sphingolipid-dependent apoptosis of neu-
ronal stem cells in the ventricular zone and cell survival in
the intermediate zone is regulated by a two-step mechanism.
Ceramide-induced apoptosis of subventricular stem cells re-
lies on the simultaneous expression of ceramide and PAR-4
and its asymmetric distribution during mitotic cell division.
Only the PAR-4( ) daughter cells will undergo ceramide-
induced apoptosis and make room for nestin( )/PAR-4( )
NP cells. In the second step, ceramide is converted to cer-
amide-1-phosphate, glycosphingolipids, and/or sphingomy-
elin, thus protecting progenitor cells from further ceramide
accumulation. The simultaneous elevation of ceramide and
PAR-4, and subsequent apoptosis in nestin( ) cells may
thus be a mechanism to select for nestin( ) neuronal pro-
genitors, or may be a mechanism to eliminate young post-
mitotic neurons via expression of high levels of PAR-4 and
ceramide. In future experiments, we will determine which
endogenous and exogenous signals orchestrate sphingolipid
biosynthesis and the expression/asymmetric distribution of
PAR-4 and nestin during neural differentiation of stem cells
in vitro and embryonic mouse brain in vivo.
Materials and methods
Materials
ES-J1 and feeder fibroblasts were obtained from the ES core facility, Medi-
cal College of Georgia. Knockout DME, neurobasal, knockout serum re-
placement, ES-qualified FBS, N2 supplement, and FGF-2 were from Invi-
trogen. DME/Ham’s F-12 50/50 mix was purchased from Cellgro, and
ESGRO leukemia inhibitory factor (LIF) was from CHEMICON Interna-
tional. Nonenzymatic cell dissociation solution, diacylglycerol kinase from
Escherichia coli, FB1, myriocin, BrdU, ceramide standard, Hoechst 33258,
polyclonal anti-PKC  rabbit IgG, polyclonal anti-GFAP rabbit IgG, poly-
clonal anti-vimentin goat IgG, monoclonal anti-MAP2a/b mouse IgG, and
goat anti–rabbit IgG HRP conjugate were obtained from Sigma-Aldrich.
Polyclonal anti-Oct4 rabbit IgG, polyclonal anti-PAR-4 rabbit IgG, poly-
clonal anti-PAR-4 goat IgG, monoclonal anti-PAR-4 mouse IgG, poly-
clonal anti-caspase 3 rabbit IgG, polyclonal anti-synaptophysin rabbit IgG,
polyclonal anti-BrdU sheep IgG, and polyclonal anti-PCNA rabbit IgG
were from Santa Cruz Biotechnology, Inc. Polyclonal anti-cleaved caspase
3 rabbit IgG, monoclonal anti-Bcl-2 mouse IgG, and monoclonal anti-
phospho Bcl-2 antagonist of death mouse IgG were purchased from Cell
Signaling. Anti-nestin mouse monoclonal IgG (clone Rat 401) was from
BD Biosciences, and monoclonal anti-ceramide mouse IgM (clone 15B4)
was from Alexis. Goat anti–rabbit IgG Alexa
® 488 conjugate and goat anti–
mouse IgG Alexa
® 546 conjugate were obtained from Molecular Probes,
Inc. Goat anti–rabbit IgG Cy5 conjugate, donkey anti–rabbit IgG Cy3 con-
jugate, donkey anti–mouse IgM Cy3 conjugate, donkey anti–sheep IgG
Cy2 conjugate, and goat anti–mouse IgG HRP conjugate were purchased
from Jackson ImmunoResearch Laboratories. Goat anti–mouse IgM FITC
conjugate was from ICN Biomedicals. The cell-permeable caspase 9 inhib-
itor peptide LEHD-CHO was from Calbiochem. HPTLC plates were pur-
chased from Merck. All reagents were of analytical grade or higher, and
solvents were freshly redistilled before use.
Figure 10. A model for asymmetric apoptosis 
of NP daughter cells due to the asymmetric 
distribution of nestin and PAR-4 proteins. Before 
mitosis or during S-phase, NP cells up-regulate the 
expression of nestin, PAR-4, and ceramide. During 
cell division, ceramide is distributed equally to 
the daughter cells, whereas PAR-4 and nestin are 
restricted to different daughter cells. The daughter 
cell with simultaneous presence of PAR-4 and 
ceramide will die due to apoptosis, whereas the 
one containing ceramide and nestin will again 
divide or differentiate. Conversion of ceramide 
to sphingomyelin and/or glycosphingolipids due 
to up-regulation of sphingomyelin or glucosyl- 
or galactosylceramide biosynthesis protects this 
cell from apoptosis on further cell division or 
differentiation.T
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In vitro neuronal differentiation of ES cells
In vitro neuronal differentiation of mouse ES cells (ES-J1, ES-D3) followed
a serum deprivation protocol (Okabe et al., 1996; Hancock et al., 2000).
In brief, ES cells were grown on  -irradiated feeder fibroblasts for 4 d in
knockout DME/15% knockout serum replacement, supplemented with
ESGRO (LIF). ES cells were then passaged onto gelatin-coated tissue cul-
ture dishes without feeder fibroblasts and incubated for 4 d in knockout
DME/15% heat-inactivated ES-qualified FBS, supplemented with 1,000
U/ml ESGRO (LIF). On trypsinization, ES cells were transferred to bacterial
culture dishes without gelatin in order to allow EB formation. EBs were in-
cubated for 4 d in knockout DME/10% heat-inactivated ES-qualified FBS.
We refer to this stage as EB4. On the fifth day, floating and loosely at-
tached EBs were rinsed off, transferred to tissue culture dishes, and incu-
bated overnight in knockout DME, 10% heat-inactivated ES-qualified FBS
to the allow the EBs to attach to the dish. Neuronal differentiation due to
serum deprivation was induced by cultivation for 3 d in DME/Ham’s F12
(50/50), 1  N2 supplement. We refer to this stage as EB8. Serum-
deprived EBs were then trypsinized or treated with a nonenzymatic cell
dissociation solution, plated on poly-L-ornithine/laminin–coated tissue
culture dishes and grown for 4 d in DME/Ham’s F12 (50/50), supple-
mented with 1  N2 and 10 ng/ml FGF-2. We refer to this incubation pe-
riod as the neuroprogenitor (NP) stage due to the selective expansion of
NP cells in the FGF-2 containing serum-free medium. We refer to NP cells
grown for 48 h after replating of trypsinized EBs as the NP2 stage. On the
fifth day of NP formation, the medium is changed to neurobasal, 5% heat-
inactivated FBS, and cells are incubated for another 7 d. During this time,
NP cells become fully differentiated to glial cells and neurons. We refer to
24 or 96 h of differentiation as the D1 or D4 stages, respectively (see Fig.
1 for diagram of differentiation protocol).
Ceramide analysis and preparation of 
ceramide-containing medium
The extraction and quantitative determination of ceramide by HPTLC fol-
lowed a standard protocol as described previously (Bieberich et al., 2001).
Lipids were stained with 3% cupric acetate in 8% phosphoric acid for
quantification by comparison with various amounts of standard lipids. For
quantitative determination of ceramide using the DAG kinase assay ac-
cording to Signorelli and Hannun (2002). For incubation of FB1- or myrio-
cin-treated (ceramide-depleted) differentiating ES cells with natural cer-
amide, 50 mg EBs or NP cells were resuspended in 500  l of water, and
after phase separation with 500  l of CHCl3/CH3OH (1:1, vol/vol), the
neutral lipids recovered from the lower phase. The neutral lipids were
evaporated to dryness with a gentle stream of nitrogen and were redis-
solved in 1 ml CHCl3. The solution was applied to a 0.5-g silicic acid gel
column, and fatty acids and cholesterol were washed out with another 15
ml CHCl3 (Dasgupta and Hogan, 2001). The ceramide fraction was then
eluted with 20 ml of CHCl3/acetone (9:1, vol/vol), evaporated to dryness,
and the residue ( 6 nmol of ceramide) dissolved in 20  l ethanol contain-
ing 2% dodecane (vol/vol). 5- l aliquots were mixed with 1 ml medium
yielding a final concentration of 1.5  M natural ceramide for induction of
apoptosis (Ji et al., 1995).
BrdU labeling, immunofluorescence microscopy, 
and TUNEL assay
Differentiating ES cells at the EB8 stage were dissociated and grown for 24 h
on laminin/ornithin-coated coverslips (NP1 stage) in DME/Ham’s F12
(50/50), supplemented with 1  N2 and 20 ng/ml FGF-2. Cells were incu-
bated for 3 h with 10  M BrdU, and the TUNEL assay or immunostainings
were performed after 5 h of incubation. For immunostaining, cells were
fixed with 4% PFA in PBS. Fixed cells were permeabilized with 0.2% Tri-
ton X-100 in PBS for 5 min at RT, and immunostaining was performed as
described previously (Bieberich et al., 2001). The nuclei were stained by
treatment with 2  g/ml Hoechst 33258 in PBS for 30 min at RT. Apoptotic
nuclei were stained using the fluorescein FragEL™ TUNEL assay according
to instructions of the manufacturer (Oncogene Research Products).
Statistical analysis
Antigen-specific immunostaining was quantified by counting cells that
showed signals twofold or more above background fluorescence. Cell
counts were performed in five areas of  200 cells that were obtained from
three independent immunostaining reactions. A Chi-square test with one
degree of freedom was applied for the statistical analysis of the distribution
of two immunostained antigens. The first null hypothesis (H0
1) to be re-
futed was that the two antigens were independently distributed within the
total cell population (mean of 200 cells in five counts). The expected fre-
quency for double staining was the frequency product for immunostaining
of A or B in the total population, f(A and B)   f(A)   f(B). The second null
hypothesis (H0
2) to be refuted was that the frequency of antigen B in the
subpopulation A was identical to its frequency in the total population, f(B
in A)   f(B in A   B).
RNA preparation and RT-PCR
Total RNA was prepared from differentiating stem cells using the TRIzol
®
method according to the manufacturer’s protocol (Life Technologies). An
aliquot (0.6–1.0  g RNA) was used for RT-PCR with the ThermoScript
TM
RT-PCR system following the supplier’s instructions (Invitrogen). PCR was
performed by applying 35 cycles with various amounts of first-strand
cDNA template (equivalent to 0.05–0.2  g of RNA) and 20 pmol of sense
and antisense oligonucleotide primer. The following oligonucleotide
primer sequences and annealing temperatures were used: PAR-4 (sense,
5 -ccagcgccaggaaaggcaaag-3 ; antisense, 5 -ctaccttgtcagctgcccaacaac-3 ;
61 C), PKC  (sense, 5 -agccacgccgtttggaaagg-3 ; antisense, 5 -acactttattc-
ctcagggcattacacg-3 ; 58 C), SPT1 (sense, 5 -gctaacatggagaatgcactc-3 ;
antisense, 5 -cttcctccgtctgctccac-3 ; 53 C), and GAPDH (sense, 5 -gaa-
ggtgaaggtcggagtcaacg-3 ; antisense, 5 -ggtgatgggatttccattgatgacaagc-3 ;
58 C). The amount of template from each sample was adjusted until PCR
yielded equal intensities of amplification for GAPDH.
Construction of PAR-4-RFP cDNA and transfection 
of EB-derived cells
For construction of PAR-4-RFP cDNA, RT-PCR was performed with the oli-
gonucleotide primer pair sense 5 -atggcgaccggcggctatcg-3  and antisense
5 -ctaccttgtcagctgcccaacaac-3  using the first-strand cDNA generated from
EBs (EB8 stage) as template for the amplification reaction. The primers
were endowed with the restriction enzyme cleaving sites Eco47III (sense)
and SalI (antisense) for ligation of the PAR-4–specific amplification product
into the multiple cloning site of HcRFP, a vector that encodes a far-red–
shifted variant of red fluorescent protein (CLONTECH Laboratories, Inc.).
Differentiating ES cells at the NP1 stage were transfected with the PAR-4-
RFP construct using the LipofectAMINE™ 2000 procedure according to
the manufacturer’s instructions (Invitrogen). The transfected cells were in-
cubated in DME/Ham’s F12 (50/50), supplemented with 1  N2 and 20 ng/
ml FGF-2, and the TUNEL assay or immunostainings were performed after
48 h of incubation and NP formation. For depletion of ceramide, differen-
tiating ES cell were incubated with 25  M FB1 or 50 nM myriocin 48 h be-
fore transfection with the PAR-4-RFP vector, and the inhibitor was main-
tained in the medium throughout the post-transfection period. For
induction of apoptosis, the novel ceramide analogue S18 (40–100  M),
N-acetyl sphingosine (C2-ceramide; 10–30  M), or natural ceramide iso-
lated from EBs (0.5–1.5  M, for preparation see section on ceramide anal-
ysis) was added 48 h after transfection with the PAR-4-RFP cDNA, and the
degree of apoptosis was quantified after 15–20 h using TUNEL assays with
PFA-fixed cells as described in the section on BrdU labeling.
Morpholino antisense knockdown of endogenous PAR-4
Endogenous expression of PAR-4 was suppressed by transfection of differ-
entiating ES cells at the NP1 stage with 2 nmol (per well in 24-well plates)
of the morpholino-based antisense oligonucleotide 5 -cgatagccgccggtcgc-
catgttcc-3  (for sequence see Guo et al., 1998, 2001) following the instruc-
tions of the manufacturer (GeneTools) in 0.5 ml serum-free DME/Ham’s
F-12 and 1  N2 supplemented with 20 ng/ml FGF-2. For induction of
apoptosis, the novel ceramide analogue S18 (40–100  M), N-acetyl sphin-
gosine (C2-ceramide; 10–30  M), or natural ceramide isolated from EBs
(0.5–1.5  M, for preparation see section on ceramide analysis) was added
48 h after transfection with the anti-PAR-4 morpholino, and the degree of
apoptosis was quantified after 15–20 h using TUNEL assays with PFA-fixed
cells as described in the section on BrdU labeling.
Protein isolation and immunoblotting
The amount of protein was determined after a modified Folin phenol re-
agent (Lowry) assay as described previously (Wang and Smith, 1975). Pro-
tein extracted with detergent was precipitated according to the Wessel and
Fluegge method (Wessel and Flugge, 1984). SDS-PAGE was performed us-
ing the Laemmli method followed by immunoblotting as described previ-
ously (Laemmli, 1970).
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